Maze Therapeutics (MAZE) Times Interest Earned (2024 - 2026)

Maze Therapeutics (MAZE) posted Times Interest Earned of $7.09 for Q1 2026, up 2185.96% sequentially from -$0.34 in Q4 2025.

Maze Therapeutics (MAZE) Times Interest Earned (2024 - 2026) Analysis & Trends

Maze Therapeutics has reported Times Interest Earned for 3 years, with the latest figure at $7.09 in Q1 2026.

Quarterly Times Interest Earned changed N/A year-over-year to $7.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.78 (changed N/A YoY) and the FY2025 annual result came in at -$0.87, down 233.77% from the prior year.
Times Interest Earned advanced to $7.09 in Q1 2026 per MAZE's latest filing, from -$0.34 in the prior quarter.
Over five years, Times Interest Earned peaked at $7.09 in Q1 2026 and troughed at -$60.17 in Q4 2024.
A 3-year average of -$17.81 and a median of -$0.34 in 2025 frame the typical range for Times Interest Earned.
The widest YoY moves for Times Interest Earned: up 99.44% in 2025, down 99.44% in 2025.
Over 3 years, Times Interest Earned stood at -$60.17 in 2024, then soared by 99.44% to -$0.34 in 2025, then soared by 2185.96% to $7.09 in 2026.
According to Business Quant data, Times Interest Earned over the past three periods registered $7.09, -$0.34, and -$60.17 for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	2.84
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	24.64
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-0.19
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	8.18
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-0.01
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.61
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	2.82
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-0.08
10	Maze Therapeutics	1.51 Bn	1.51 Bn	-	13.27

Download Data